JIA Synovial Atlas Pinpoints Pathogenic Cell Niches Driving Childhood Arthritis Severity

Juvenile Idiopathic Arthritis (JIA) is the most common chronic inflammatory arthritis in children, yet treatment remains poorly targeted because the cellular and molecular basis of synovial inflammation in pediatric patients has not been systematically characterized. Imprecise therapy leads to suboptimal outcomes, prolonged disease, and unnecessary side effects. This study addressed that gap by generating a comprehensive cellular atlas of the JIA synovium.

The researchers performed synovial tissue biopsies from treatment-naïve children with JIA early in disease course and analyzed them using single-cell RNA sequencing (scRNA-seq), multiplexed immunofluorescence (MIF), and spatial transcriptomics. Matched synovial fluid and peripheral blood samples were also profiled from the same individuals, enabling cross-compartment comparisons. The cohort included patients from multiple UK pediatric rheumatology centers as part of the MAPJAG Study Group.

The atlas identified distinct spatial tissue niches composed of specific combinations of stromal and immune cells. Critically, genes associated with arthritis severity and genetic disease risk were localized to specific effector populations: SPP1+ tissue-resident macrophages and fibrin-associated myeloid cells emerged as particularly important disease-driving populations. Spatial transcriptomics confirmed the physical co-localization of these cells within discrete tissue microenvironments, suggesting they form functional pathogenic niches rather than acting in isolation.

Comparative analysis across synovial tissue, synovial fluid, and peripheral blood from the same patients revealed substantial differences in cellular composition, active signaling pathways, and transcriptional programs between compartments, underscoring that synovial fluid analysis alone is insufficient to capture tissue pathology. Comparison with adult rheumatoid arthritis (RA) data showed that while several pathogenic cell populations are shared between JIA and adult RA, important age-associated distinctions exist: JIA synovium displayed greater tissue vascularity, more prominent innate immune activity, and an enrichment of TGF-β-responsive stromal subsets that upregulate expression of disease-risk genes—differences that could have direct therapeutic implications.

These findings argue strongly for age-specific analyses of synovial pathology and challenge the assumption that treatment strategies validated in adult RA can be directly extrapolated to children. The identification of SPP1+ macrophages and fibrin-associated myeloid cells as disease-severity hubs provides concrete cellular targets for future therapeutic development and biomarker discovery in JIA.